Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

✍ Scribed by Mark Clemons; Anil A. Joy; Radhi Abdulnabi; Mauricio Kotliar; Jodi Lynch; Johan P. Jordaan; Neill Iscoe; Karen Gelmon

• Publisher: Springer US
• Year: 2010
• Tongue: English
• Weight: 317 KB
• Volume: 124
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-010-1152-0